Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.

Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ.

Nat Immunol. 2007 Dec;8(12):1353-62. Epub 2007 Nov 4.

PMID:
17982458
2.

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.

Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W.

Cancer Res. 2007 Aug 1;67(15):7487-94.

3.

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Bäckström BT, Sobel RA, Wucherpfennig KW, Strom TB, Oukka M, Kuchroo VK.

Nat Med. 2007 Apr;13(4):423-31. Epub 2007 Mar 25.

4.

Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VE, Gonzalez-Munoz A, Clark J, Veijola R, Cubbon R, Chen SL, Rosa R, Cumiskey AM, Serreze DV, Gregory S, Rogers J, Lyons PA, Healy B, Smink LJ, Todd JA, Peterson LB, Wicker LS, Santamaria P.

Nat Genet. 2007 Mar;39(3):329-37. Epub 2007 Feb 4.

5.

Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.

Villarino AV, Tato CM, Stumhofer JS, Yao Z, Cui YK, Hennighausen L, O'Shea JJ, Hunter CA.

J Exp Med. 2007 Jan 22;204(1):65-71. Epub 2007 Jan 16.

6.

The tumor-draining lymph node as an immune-privileged site.

Munn DH, Mellor AL.

Immunol Rev. 2006 Oct;213:146-58. Review.

PMID:
16972902
7.

Clearance of apoptotic and necrotic cells and its immunological consequences.

Krysko DV, D'Herde K, Vandenabeele P.

Apoptosis. 2006 Oct;11(10):1709-26. Review.

PMID:
16951923
8.

The role of regulatory T cells in alloantigen tolerance.

Aluvihare VR, Betz AG.

Immunol Rev. 2006 Aug;212:330-43. Review.

PMID:
16903924
9.

Infectious tolerance and the long-term acceptance of transplanted tissue.

Waldmann H, Adams E, Fairchild P, Cobbold S.

Immunol Rev. 2006 Aug;212:301-13. Review.

PMID:
16903922
10.

Natural regulatory T cells and parasites: a common quest for host homeostasis.

Belkaid Y, Blank RB, Suffia I.

Immunol Rev. 2006 Aug;212:287-300. Review.

PMID:
16903921
11.

Regulatory T cells in virus infections.

Rouse BT, Sarangi PP, Suvas S.

Immunol Rev. 2006 Aug;212:272-86. Review.

PMID:
16903920
12.

Regulatory T-cell physiology and application to treat autoimmunity.

Tang Q, Bluestone JA.

Immunol Rev. 2006 Aug;212:217-37. Review.

PMID:
16903917
13.

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T.

Immunol Rev. 2006 Aug;212:8-27. Review.

PMID:
16903903
14.

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J.

Science. 2006 Mar 31;311(5769):1924-7. Epub 2006 Feb 16.

15.

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.

Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA.

Nat Immunol. 2006 Jan;7(1):83-92. Epub 2005 Nov 27.

16.

Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.

Chen Z, Herman AE, Matos M, Mathis D, Benoist C.

J Exp Med. 2005 Nov 21;202(10):1387-97.

17.

Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen.

Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK.

J Exp Med. 2005 Nov 21;202(10):1375-86. Epub 2005 Nov 14.

18.

A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY.

Nat Immunol. 2005 Nov;6(11):1142-51. Epub 2005 Oct 16. Erratum in: Nat Immunol. 2006 Apr;7(4):427.

PMID:
16227984
19.
20.

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.

Nature. 2005 May 12;435(7039):220-3.

Supplemental Content

Support Center